Navigation Links
Enobia Announces Positive Clinical Results With ENB-0040, a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia
Date:9/14/2009

DENVER, Sept. 14 /PRNewswire/ -- Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development. These findings were presented by Dr. Michael Whyte at the 31(st) Annual Meeting of the American Society for Bone and Mineral Research in Denver, CO.

HPP is a genetic disease characterized primarily by defective bone mineralization and is caused by a deficiency in the enzyme tissue non-specific alkaline phosphatase (TNSALP). This enzyme plays a key role in regulating skeletal mineralization. There are currently no therapies approved for HPP. As an enzyme replacement therapy designed to specifically target TNSALP to the bones, ENB-0040 may help correct the enzyme deficiency and restore bone mineralization.

"Poor bone formation in infants with severe hypophosphatasia has devastating consequences, including fractures, respiratory failure and death in approximately half the infants," stated Michael P. Whyte, M.D., Medical/Scientific Director of the Center for Metabolic Bone Disease and Molecular Research at Shriners Hospitals for Children in St. Louis and an investigator for the study. "The findings from this study are very encouraging, as they demonstrate correction of the primary skeletal disturbance after treatment with ENB-0040."

"The results from this study in infants and young children mark an important milestone for our program," said Hal Landy, M.D., Chief Medical Officer and Vice President, Medical Affairs of Enobia. "We are pleased that all five patients who completed the s
'/>"/>

SOURCE Enobia Pharma Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease
2. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
3. Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
4. Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
5. Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial
6. Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
7. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
8. Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
9. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
10. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
11. BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... NEW YORK , July 29, 2014 /PRNewswire/ ... team of Caremark Rx, Drew Crawford today ... PBM365 is the leading independent media source dedicated to ... and opinion on the pharmacy benefit management (PBM) industry ... timely coverage of, and context behind, industry news.   The ...
(Date:7/29/2014)... July 29, 2014  Roche (SIX: RO, ROG; OTCQX: ... Clinical Chemistry (AACC) 2014 Clinical Lab Expo today by ... unique ways Roche is partnering with customers to redefine ... tell us every day that they,re looking for a ... in their labs and offices," said Jack Phillips ...
(Date:7/29/2014)... Laboratory (IL) today announced the launch of its new corporate ... of a comprehensive rebranding effort by Werfen, the parent company ... , in 1959, IL has been part of the ... the group include Inova Diagnostics ( San Diego, CA ... ).  Like IL, these three companies are focused on ...
Breaking Medicine Technology:Drew Crawford Announces Launch of PBM365 Media 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3
... 2007 -,Icagen, Inc. (NASDAQ: ICGN) today announced that ... at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference ... 2:00 p.m. ET., There will be a live ... will be accessible through a link posted on,the ...
... --,SuperGen, Inc. today announced that Dr. Gregory Berk, ... Towbin Emerging Growth,Opportunities Conference on Thursday, July 12, ... City. , SuperGen's presentation at the C.E. Unterberg, ... at 3:30 p.m.,EDT. A live webcast of the ...
Cached Medicine Technology:Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2
(Date:7/29/2014)... are chemical substances, which are able to kill unwanted ... prevent degradation of the physical and sensorial properties of ... used in various applications such as water treatment, personal ... It is also used in domestic applications such as ... to prevent fouling in water and oil pipelines. , ...
(Date:7/29/2014)... use of electronic medical records and health information ... computerized version of the preventive care guidelines pediatricians ... study, researchers from the Indiana University School of ... work lies ahead to convert the American Academy ... for physicians, but the payoff has the potential ...
(Date:7/29/2014)... 29, 2014 The Latin American poultry feed ... with analysis and forecast of revenue. The poultry feed and ... from $25,273.3 million and $647.2 million in 2013 to $34,024.0 ... 6.1% from 2013 to 2018, respectively. , To get an ... the TOC of the Latin American poultry feed and feed ...
(Date:7/29/2014)... HealthDay Reporter MONDAY, July 28, ... continues to rage throughout West Africa poses little risk to ... through physical touch, and it can,t be spread by people ... of the National Center for Emerging & Zoonotic Infectious Diseases ... in a Monday afternoon news conference. Those factors -- ...
(Date:7/29/2014)... including Penn State College of Medicine, have jointly ... a health data research network., The Patient-Centered Outcomes ... Patient Protection and Affordable Care Act, awarded the ... University and Johns Hopkins University -- and each ... have come together to create a Clinical Data ...
Breaking Medicine News(10 mins):Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 5Health News:CDC Downplays Ebola's Threat to the United States 2Health News:CDC Downplays Ebola's Threat to the United States 3Health News:CDC Downplays Ebola's Threat to the United States 4Health News:New network unites university health care research 2
... sickle cell disease who also have lower blood oxygen ... have heart abnormalities, researchers at Washington University School of ... Heart problems are fairly common in young adults ... why. The researchers demonstrated that lower oxygen saturation in ...
... ... (radial Keratotomy) may benifit from PRELEX with crystalens according to Dr. Khanna. , ... (Vocus) April 27, 2010 -- Patents that ... Khanna. Radial Keratotomy was in vogue in the late seventy’s and eighties. Its popularity declined ...
... function , TUESDAY, April 27 (HealthDay News) -- High-dose ... and patients on this regimen should stop immediately, says a ... believed it would show that high-dose vitamin B therapy (folic ... function and reduce their risk of heart attack and stroke. ...
... study finds problems contracting, relaxing, , TUESDAY, April 27 ... the heart more than had been thought, a new ... what might be the first clear evidence that these ... damage heart function, said Dr. Aaron L. Baggish, an ...
... Digestive Health and Nutrition (FDHN) announced this year,s recipient ... Kenneth P. Olive, PhD. The $225,000 gift from ... with funding and protected time for three years to ... Schwartz, a businessman and photographer, suffered from the disease ...
... ... to select their perfect retirement community based on community culture, personality, amenities and personal preferences. ... Princeton, NJ (PRWEB) ... can be a complicated, confusing chore. In fact, retirees and their families must choose ...
Cached Medicine News:Health News:Low blood oxygen may lead to heart defects in children with sickle cell disease 2Health News:Low blood oxygen may lead to heart defects in children with sickle cell disease 3Health News:Crystalens HD May Help People with RK 2Health News:Steroids Could Harm Heart's Pumping Ability 2Health News:Steroids Could Harm Heart's Pumping Ability 3Health News:Second AGA Foundation/Bernard Lee Schwartz Foundation Research Scholar Award presented 2Health News:RetiringbyDesign.com Offers Retirees a Smarter Way to Explore Living Options 2Health News:RetiringbyDesign.com Offers Retirees a Smarter Way to Explore Living Options 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: